Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Should the other testis be biopsied?

G Daugaard1, A Giwercman, N E Skakkebaek

  • 1Department of Oncology, Finsen Center, Rigshospitalet, Copenhagen, Denmark.

Seminars in Urologic Oncology
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains.

Journal of endocrinological investigation·2023
Same author

Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.

Acta oncologica (Stockholm, Sweden)·2023
Same author

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same journal

The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.

Seminars in urologic oncology·2002
Same journal

Poor prognosis germ-cell tumors: An unresolved challenge.

Seminars in urologic oncology·2002
Same journal

Chemotherapy for good-risk germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?

Seminars in urologic oncology·2002
Same journal

Controversies in the management of testicular seminoma.

Seminars in urologic oncology·2002
See all related articles

Bilateral testicular tumors occur in 5% of cases. A contralateral testis biopsy in testicular tumor patients can reveal carcinoma in situ (CIS), which requires optimal treatment.

Area of Science:

  • Oncology
  • Urology
  • Pathology

Background:

  • Testicular tumors can be bilateral in approximately 5% of cases.
  • Carcinoma in situ (CIS) is found in 5-6% of contralateral testis biopsies in testicular tumor patients.
  • Untreated CIS has a high risk of progressing to invasive testicular germ cell tumors.

Purpose of the Study:

  • To highlight the significance of contralateral testis biopsy in identifying carcinoma in situ (CIS).
  • To emphasize the importance of diagnosing CIS for optimal patient treatment.
  • To discuss the varying clinical practices regarding contralateral biopsies in different countries.

Main Methods:

  • Review of existing literature and clinical data on testicular tumors and CIS.
  • Analysis of the incidence of bilaterality and CIS in contralateral testes.

Related Experiment Videos

  • Comparison of diagnostic and treatment policies across different healthcare systems.

    • Main Results:

    • Approximately 5% of testicular tumor cases present with bilateral tumors.
    • Carcinoma in situ (CIS) is detected in 5-6% of contralateral testicular biopsies.
    • The diagnosis of CIS is crucial for initiating timely and appropriate treatment, preventing progression to invasive tumors.

    Conclusions:

    • Contralateral testis biopsy is a valuable diagnostic tool in patients with testicular tumors.
    • Early detection of CIS through biopsy enables effective management and improves patient outcomes.
    • Standardizing the practice of contralateral biopsy could enhance the detection and treatment of testicular germ cell tumors.